Cargando…
Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
Autores principales: | Young, Peter A., Keller, Lia C., Bae, Gordon H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895670/ https://www.ncbi.nlm.nih.gov/pubmed/33644278 http://dx.doi.org/10.1016/j.jdcr.2020.12.030 |
Ejemplares similares
-
Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib
por: Pinard, Camille, et al.
Publicado: (2017) -
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
por: Maximova, Natalia, et al.
Publicado: (2020) -
Successful use of carbamazepine in a patient with drug rash with eosinophilia and systemic symptoms
por: Bixby, Alexandra L., et al.
Publicado: (2019) -
Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Due to Vancomycin
por: Kulkarni, Mugdha P, et al.
Publicado: (2022) -
Ceftriaxone induced drug rash with eosinophilia and systemic symptoms
por: Guleria, Vivek S., et al.
Publicado: (2014)